Journal of Oral Science Research ›› 2023, Vol. 39 ›› Issue (10): 911-916.DOI: 10.13701/j.cnki.kqyxyj.2023.10.012

Previous Articles     Next Articles

Preparation of Capsaicin Nanoparticles and Their Effect on Treatment of Trigeminal Neuralgia in Rats

XIONG Yu1,2,3, ZHENG Xinxin1,2,3, CHEN Jinglin1,2,3, CHEN Lizhen1,2,3, JIN Youhong1,2,3*, WANG Pei2,3   

  1. 1. Department of Periodontology, The Affiliated Stomatological Hospital of Nanchang University, Nanchang 330006, China;
    2. The Key Laboratory of Oral Biomedicine, Nanchang 330006, China;
    3. Jiangxi Province Clinical Research Center for Oral Diseases, Nanchang 330006, China
  • Received:2023-04-17 Online:2023-10-28 Published:2023-10-25

Abstract: Objective: To prepare capsaicin (Cap) nanoparticles and develop them into gel to observe their therapeutic effect on trigeminal neuralgia in rats. Methods: Cap-loaded polylactic-co-glycolic acid/Cap nanoparticles (PLGA/Cap NPs) were prepared using PLGA as the carrier and bovine serum albumin as the stabilizer by emulsion solvent evaporation method. The nanoparticles were characterized by scanning electron microscopy-energy dispersive spectroscopy, Fourier transform infrared spectroscopy, high sensitivity zeta potential analyzer, and nanoparticle size analyzer. Differential scanning calorimetry was used to analyze the properties of the nanoparticles. The Cap nanoparticles were then prepared into gel with Carbopol 934. The drug loading capacity, encapsulation efficiency, and in vitro release performance were determined by high-performance liquid chromatography. Finally, they were applied to the surgical site of rat trigeminal neuralgia to observe the efficacy. Results: At a dose of 17 mg, PLGA/Cap NPs had regular spherical shape with hydrated particle size of (389.58±12.02) nm; polymer dispersity index (PDI) of 0.270±0.018; Zeta potential of (33.56±2.61) mV; drug loading capacity of (57.56±0.05)%; encapsulation efficiency of (90.26±0.90)%; and maximum cumulative release rate of 77.19%. After applying 0.03%, 0.3%, or 3% PLGA/Cap NP gels to the surgical site in rats' faces, trigeminal pain threshold was significantly increased (P<0.05). The level of substance P (SP) and prostaglandin E2 (PGE2) in serum were significantly decreased in the treatment group compared with the model group (P<0.05). Conclusion: Cap nano-gel has certain therapeutic effects on rat trigeminal neuralgia.

Key words: capsaicin, trigeminal neuralgia, substance P, prostaglandin E2